title: Adverse Health Effects of Intermittent vs Continuous Androgen Deprivation Therapy for Metastatic Prostate Cancer-Reply.
authors.affiliation: Department of Medicine and the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York2New York Presbyterian Hospital, New York, New York3Fred Hutchinson Cancer Research Center, Seattle, Washington.
authors.forename: Dawn L
authors.initials: DL
authors.lastname: Hershman
authors.affiliation: Department of Medicine and the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York2New York Presbyterian Hospital, New York, New York3Fred Hutchinson Cancer Research Center, Seattle, Washington.
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Unger
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects; D000728:Androgens / Q000378:metabolism*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000503:physiopathology*; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*
chemical_list: D000726:Androgen Antagonists; D000728:Androgens